North Peninsula Podiatry Group Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 560 Jenevein Ave, San Bruno, CA 94066 Phone: 650-588-9189 Fax: 650-588-2814 |
North Peninsula Podiatry Group, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 560 Jenevein Avenue, San Bruno, CA 94066 Phone: 650-588-9189 Fax: 650-588-2814 |
Robert Edward Tang, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 560 Jenevein Ave, San Bruno, CA 94066 Phone: 650-588-9189 Fax: 650-588-2814 |
Dr. Arman A Kirakosian, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 560 Jenevein Ave, San Bruno, CA 94066 Phone: 650-588-9189 Fax: 650-588-2814 |
North Peninsula Podiatry Group Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 560 Jenevein Ave, San Bruno, CA 94066 Phone: 650-588-9189 Fax: 650-588-2814 |
News Archive
Tendyne Holdings, Inc., a privately held clinical stage medical device company, announced today that in November 2014 the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial, which aims to generate insight into the safety and performance of the Tendyne device in inoperable patients suffering from mitral regurgitation.
Results from a 24-week Phase 3 clinical study demonstrated that the addition of the investigational drug dapagliflozin achieved reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients who were treated with insulin (with or without oral anti-diabetes medications (OADs)), compared to placebo plus insulin (with or without OADs).
New science in cancer, genetic testing, molecular diagnostics, medical ethics, and gender-based disorders will be featured topics when nearly 1,200 pathologists gather at the Hyatt Regency Chicago on September 26 - 29 for the annual scientific meeting of the College of American Pathologists (CAP).
Observational studies measuring homocysteine concentrations in healthy individuals have found that, on average, those with high levels of homocysteine in their blood are more likely to have a stroke. But other factors that increase homocysteine concentration and stroke risk— such as smoking and socioeconomic class—may be responsible for the relationship observed in these studies, confounding the result.
› Verified 5 days ago